342 related articles for article (PubMed ID: 16575334)
1. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
3. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
4. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
[TBL] [Abstract][Full Text] [Related]
5. The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.
Wernicke AG; Sherr DL; Schwartz TH; Pannullo SC; Stieg PE; Boockvar JA; Moliterno JA; Ivanidze J; Trichter S; Sabbas AM; Parashar B; Nori D
Brachytherapy; 2010; 9(1):91-9. PubMed ID: 19850535
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.
Wernicke AG; Sherr DL; Schwartz TH; Pannullo SC; Stieg PE; Boockvar JA; Ivanidze J; Moliterno JA; Parashar B; Trichter S; Sabbas AM; Nori D
J Cancer Res Ther; 2010; 6(1):65-74. PubMed ID: 20479550
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
8. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
[TBL] [Abstract][Full Text] [Related]
9. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
12. Interstitial irradiation of malignant gliomas.
Malkin MG
Rev Neurol (Paris); 1992; 148(6-7):448-53. PubMed ID: 1448665
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
[TBL] [Abstract][Full Text] [Related]
15. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
17. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
18. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
20. Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.
Siker ML; Firat SY; Mueller W; Krouwer H; Schultz CJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):765-72. PubMed ID: 21236600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
